Our data clearly showed that Beclin-1 depletion resulted in reduced migration of osteosarcoma cells by suppressing EMT, and the increased migration caused by Beclin-1 overexpression could be reversed by Siglec-15 silencing. Here, BECN1 is linked to osteosarcoma.